Editor's Note The LivaNova factory in Munich, Germany, a manufacturer of heater-cooler units used in cardiothoracic surgery, appears to be the source of a global outbreak of Mycobacterium chimaera, this study finds. Researchers matched the DNA of samples taken from 21 infected cardiothoracic surgical patients to samples from heater-cooler units…

Read More

Each year, the OR Manager Conference showcases the latest hybrid OR technology along with expert advice from clinicians and manufacturers. The 2017 conference (October 2-4 in Orlando, Florida) will feature an extensive exhibit and opportunities to interact with the Hybrid OR Steering Committee members (sidebar, p 15): • Monday, 2…

Read More

Editor's Note Cardiac surgical team members recognize distinct critical time points during cardiac surgery, but a high degree of variability exists between members as to the importance of these times, which suggests an absence of a shared mental model, this study finds. Cardiac team members from three institutions developed a…

Read More

Editor's Note Thirty-day data from the 225-patient LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair) Study showed that at least 28% more women became eligible for  minimally invasive endovascular abdominal aortic aneurysm (AAA) repair when using Endologix’s (Irvine, California) Ovation abdominal stent graft system, according…

Read More

Editor's Note The Food and Drug Administration (FDA) on May 23 identified the recall by Abbott-Thoratec (Pleasanton, California) of its HeartMate II Left Ventricular Assist (LVAS) Pocket System Controller as Class I, the most serious. Abbott-Thoratec has receives 70 reports of incidents in which the controller malfunctions after an exchange,…

Read More

Editor's Note The Food and Drug Administration on May 16 announced the recall by Abbott of specific lots of three coronary dilation and balloon catheters: NC Trek RX Coronary Dilation Catheter NC Traveler Coronary Dilation Catheter NC Tenku RX PTCA Balloon Catheter. The affected lots were manufactured between January 2015…

Read More

Editor's Note Conscious sedation is a safe and viable option for anesthesia in patients having transcatheter aortic valve replacement (TAVR), finds this study. The use of conscious sedation rather than general anesthesia was associated with: similar rates of adverse events (1.5% in both groups) shortened ICU (30 vs 96 hours)…

Read More

Editor's Note In an interim final rule, the Centers for Medicare and Medicaid Services (CMS) has delayed expansion of the Comprehensive Care for Joint Replacement (CJR) bundled payment program and  implementation of its bundled payment programs for cardiac care from July 1 to October 1, 2017, the March 20 Modern…

Read More

Editor's Note The Food and Drug Administration (FDA) on March 18 issued a Safety Alert for Abbott Vascular’s (Santa Clara, California) Absorb GT1 Bioresorbable Vascular Scaffold (BVS). The alert was issued to inform healthcare providers of an increased rate of major adverse cardiac events in patients receiving the BVS, when…

Read More

Editor's Note In this study, the composite outcomes of death, stroke, myocardial infarction, renal failure, or repeat revascularization at 5 year follow-up were similar for patients who had off-pump and on-pump coronary artery bypass grafting (CABG) procedures. The researchers also found no significant difference in cost or quality of life…

Read More